Lekhansh Shukla
Overview
Explore the profile of Lekhansh Shukla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mukherjee D, Lakshmi N, Mahadevan J, Shukla L
Prim Care Companion CNS Disord
. 2020 Apr;
22(2).
PMID: 32302072
No abstract available.
12.
Mukherjee D, Shukla L, Saha P, Mahadevan J, Kandasamy A, Chand P, et al.
Asian J Psychiatr
. 2020 Mar;
49:101978.
PMID: 32120298
Background: Tapentadol is a synthetic opioid analgesic available in India since 2011. International evidence suggests a low risk of abuse and diversion. Our study aims to question this perception in...
13.
Shukla L, Ghadigaonkar D, Murthy P
Indian J Crit Care Med
. 2020 Feb;
23(Suppl 4):S296-S304.
PMID: 32021008
How To Cite This Article: Shukla L, Ghadigaonkar DS, Murthy P. Poisoning with Drugs of Abuse: Identification and Management. Indian J Crit Care Med 2019;23(Suppl 4):S296-S304.
14.
Muruganandam P, Shukla L, Sharma P, Kandasamy A, Chand P, Murthy P
Asian J Psychiatr
. 2019 Jul;
44:58-60.
PMID: 31325758
Background: Opioid substitution therapy is an evidence-based treatment for opioid dependence syndrome. Retention in treatment is a crucial mediator of treatment success. Our study aims to examine factors associated with...
15.
Narasimha V, Patley R, Shukla L, Benegal V, Kandasamy A
J Dual Diagn
. 2019 Jun;
15(3):172-176.
PMID: 31161915
The objective of the study was to examine the correlates, phenomenology, and short-term treatment response to benzodiazepines and antipsychotics in an inpatient sample with alcohol-induced psychotic disorder, predominant hallucinations i.e.,...
16.
Dcruz M, Shukla L, Andrade C
Indian J Psychol Med
. 2019 May;
41(3):299-300.
PMID: 31142940
No abstract available.
17.
Narasimha V, Shukla L, Shyam R, Kandasamy A, Benegal V
Indian J Psychiatry
. 2019 May;
61(3):228-231.
PMID: 31142898
Background: Cannabis dependence is associated with psychiatric, social, and legal consequences. Currently, there is no approved pharmacological treatment for cannabis dependence. Recent studies have reported the utility of N-acetylcysteine (NAC)...
18.
Narasimha V, Ganesh S, Reddy S, Shukla L, Mukherjee D, Kandasamy A, et al.
Alcohol Alcohol
. 2019 Feb;
54(2):148-151.
PMID: 30721993
Aim: To define the prevalence and clinical presentation of pellagra, a multi-systemic disease caused by the deficiency of niacin, in patients admitted to a tertiary addiction treatment centre in southern...
19.
Shukla L, Reddy S, Kulkarni G, Chand P, Murthy P
Prim Care Companion CNS Disord
. 2019 Jan;
21(1).
PMID: 30620452
No abstract available.
20.
Narasimha V, Mukherjee D, Shukla L, Benegal V, Murthy P
Asian J Psychiatr
. 2018 Nov;
38:27-28.
PMID: 30388459
Pattern of alcohol use and its related complications is determined by multiple factors. We studied the effects of sudden ban of alcohol during elections in a state of India. We...